Internal Medicine News - Pneumonia Treatment
Biaxin XL (clarithromycin extended-release tablets) has a new 7-day indication for the treatment of mild to moderate community-acquired pneumonia. The once-daily formulation is indicated for the treatment of community-acquired pneumonia caused by Haemophilus influenzae, H. parainfluenzae, Moraxella catarrahalis, Streptococcus pneumoniae, Chlamydia pneumoniae, and Mycoplasma pneumoniae.
Related Results
Biaxin FilmtabTeva Provides Generic Biaxin XL UpdateFDA OKs Abbott's seven-day Biaxin treatmentAndrx Receives Final Approval for Generic Biaxin XL Filmtab 500mgCourt of Appeals Rules in Favor of Teva on Biaxin XL Preliminary…
It is also indicated for mild to moderate infections in adults with acute bacterial exacerbation of chronic bronchitis.
COPYRIGHT 2002 International Medical News Group
COPYRIGHT 2008 Gale, Cengage Learning
